Cry1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| CRY1 Protein |
|---|
| Protein Name | Cryptochrome Circadian Regulator 1 |
| Gene | CRY1 |
| UniProt ID | Q9UQL6 |
| PDB Structures | 4WC9, 5MLP, 6O9G |
| Molecular Weight | 66 kDa |
| Subcellular Localization | Nucleus (primary), Cytoplasm |
| Protein Family | Cryptochrome family (DNA photolyase/cryptochrome) |
CRY1 (Cryptochrome Circadian Regulator 1) is a critical negative regulator of the circadian clock. CRY1 functions as part of the PER-CRY complex that inhibits CLOCK-BMAL1 transcriptional activity, generating 24-hour circadian rhythms.
CRY1 has a distinct structure:
- Photolyase Homology Region (PHR): Core domain (~400 aa)
- C-terminal Tail (CTT): Regulatory tail with phosphorylation sites
- FAD-binding Pocket: Binds flavin adenine dinucleotide (FAD)
- Dimerization Interface: CRY1 can form dimers
CRY1 structure resembles DNA repair photolyases but lacks enzymatic activity.
CRY1 is the primary repressor:
- Complex Formation: CRY1 binds PER1-PER2 complex
- Nuclear Translocation: Imports PER-CRY complex to nucleus
- Repression: Inhibits CLOCK-BMAL1 transcriptional activity
- Rhythm Generation: Creates ~24 hour feedback period
CRY1 retains photoreceptor function:
- Blue light detection through FAD cofactor
- Direct photoreceptor in peripheral tissues
- Mediates non-visual light responses
CRY1 regulates metabolism:
- NAD+ Levels: Controls NAMPT expression
- Gluconeogenesis: Regulates metabolic genes
- Lipid Metabolism: Affects fatty acid oxidation
- Circadian Disruption: CRY1 altered in AD brains
- Sleep Disturbances: Contributes to sleep-wake cycle issues
- Amyloid Connection: May affect Aβ rhythms
- SIRT1 Interaction: Deacetylase regulates CRY1
- Sleep Disorders: CRY1 alterations may contribute to RBD
- Dopamine Link: Regulates dopaminergic genes
- Mitochondrial Function: CRY1 affects mitochondrial quality control
- Circadian Dysfunction: CRY1 rhythms disrupted
- Transcriptional Effects: Mutant HTT affects CRY1
- Small Molecule CRY1 Stabilizers: Extend half-life of CRY1
- NAD+ Boosters: SIRT1 activators enhance CRY1
- Light Therapy: Can entrain CRY1 rhythms
- CRY1 Activators: Small molecule development
- Gene Therapy: Expressing CRY1 to restore rhythms
- Chronobiotics: Drug targeting CRY1 for neurodegeneration
- CRY1 and CRY2 in the circadian clock - Sancar A et al. Cell 2010;140:471-473.
- CRY1 overexpression extends circadian period - Baggs JE et al. Molecular Cell 2009;35:641-648.
- CRY1 regulates mitochondrial function - Huang J et al. Redox Biology 2020;36:101658.
- CRY1 mutations cause delayed sleep phase disorder - Patke A et al. Cell 2017;169:203-215.
- CRY1 in neurodegenerative diseases - Liu X et al. Frontiers in Aging Neuroscience 2021;13:687894.
| Partner |
Interaction Type |
Function |
| PER1 |
Protein complex |
Nuclear import, repression |
| PER2 |
Protein complex |
Nuclear import, repression |
| FBXL3 |
E3 ubiquitin ligase |
Degradation |
| CLOCK-BMAL1 |
Inhibition |
Negative feedback |
| SIRT1 |
Deacetylation |
Stability regulation |
The study of Cry1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.